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University of Mu¨nster, Mu¨nster, GermanyABSTRACT Ezrin is a membrane-cytoskeleton linker protein that can bind F-actin in its active conformation. Several means of
regulation of ezrin’s activity have been described including phosphorylation of Thr-567 and binding of L-a-phosphatidylinositol-
4,5-bisphosphate (PIP2). However, the relative contributions of these events toward activation of the protein and their potential
interdependence are not known. We developed an assay based on solid-supported membranes, to which different ezrin mutants
(ezrin T567A (inactive mutant), wild-type, and T567D (active pseudophosphorylated mutant)) were bound, that enabled us to
analyze the influence of phosphorylation and PIP2 binding on ezrin’s activation state in vitro. The lipid bilayers employed con-
tained either DOGS-NTA-Ni to bind the proteins via an N-terminal His-tag, or PIP2, to which ezrin binds via specific binding sites
located in the N-terminal region of the protein. Quantitative analysis of the binding behavior of all three proteins to the two
different receptor lipids revealed that all three bind with high affinity and specificity to the two receptor lipids. Fluorescence
microscopy on ezrin-decorated solid-supported membranes showed that, dependent on the mode of binding and the phosphor-
ylation state, ezrin is capable of binding actin filaments. A clear synergism between phosphorylation and the receptor lipid PIP2
was observed, suggesting a conformational switch from the dormant to the active, F-actin binding state by recognition of PIP2,
which is enhanced by the phosphorylation.INTRODUCTIONIn eukaryotic cells, the organization and dynamic properties
of the cell membrane architecture are regulated by an inter-
play between the lipid bilayer and the subjacent cortical
actin cytoskeleton. Proteins of the ezrin, radixin, and moesin
(ERM) family act as dynamic linkers between the actin
cytoskeleton and the plasma membrane, and are therefore
implicated in membrane organization in various cellular
and developmental processes (1). It is established that
ERM proteins can exist in an apparently dormant, closed
conformation that localizes in the cytoplasm and an active
form that interacts with plasma membrane proteins and
actin filaments (2–4). In the dormant conformation, the
N-terminal ERM association domain (N-ERMAD) and
the C-terminal ERM association domain (C-ERMAD) are
self-associated by a head-to-tail joining, thus masking
the F-actin and membrane protein binding sites (2). Adop-
tion of the open active conformation capable of binding
F-actin requires disruption of the N-ERMAD/C-ERMAD
interaction.
The first insights into the molecular mechanism of the
regulation of ERM proteins came with the discovery that
moesin is phosphorylated on Thr-558 located in the
C-ERMAD during platelet activation (5). Highly conserved
threonine residues in ezrin (Thr-567) and radixin (Thr-564)
were then also found to be phosphorylated leading to activa-
tion. Fo¨rster resonance energy transfer analysis withSubmitted November 16, 2010, and accepted for publication February 23,
2011.
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of Thr-567 is sufficient to disrupt the closed conformation of
ezrin (6). Phosphorylation turns the protein into the active
form, which is able to bind F-actin (7). However, in addition
to phosphorylation, evidence obtained from biochemical
and cellular assays showed that ERM proteins directly
bind to L-a-phosphatidylinositol-4,5-bisphosphate (PIP2).
This also promotes their activation (5,8–10) and can be
envisaged as the key player in the dynamics of ERM protein
regulation.
Recent reports have demonstrated that dynamic changes
in the PIP2 levels in cells can have an instructive role on
ERM protein activity (11,12). Studies on mammalian ezrin
revealed that PIP2 binding is a prerequisite for its subse-
quent phosphorylation (13). The major role of PIP2 is also
manifested by experiments of Auvinen et al. (14), who
showed that overexpression of PIPKa, an enzyme that cata-
lyzes the production of PIP2, relocates endogenous ezrin
partially to adherens junctions, suggesting opening of its
dormant state. Hao et al. (15) demonstrated that a reduction
of PIP2 levels by activation of phospholipase C promotes the
release and dephosphorylation of moesin and ezrin in
cellular systems. Based on these results, a two-step model
of activation is envisioned (12): ERM proteins are recruited
to membrane regions that are rich in PIP2, thus rendering
the conserved threonine residue more accessible to
phosphorylation.
Recently, we have developed an artificial membrane
system, which gave us what we believe to be first insights
into the influence of PIP2 binding on ezrin activation, i.e.,
F-actin binding, in a very well-defined in vitro systemdoi: 10.1016/j.bpj.2011.02.039
Synergistic Effects on Ezrin Activation 1709(16). We were able to demonstrate that ezrin bound via PIP2
to a solid-supported membrane (SSM) is capable of binding
actin filaments, while ezrin bound via a His-tag to a lipid
bilayer displaying nickel nitrilotriacetic acid (NTA-Ni)
headgroups does not significantly interact with F-actin.
In this study, we aimed at elucidating the influence of PIP2
binding and phosphorylation and its possible synergism with
respect to activation of ezrin’s F-actin binding. We made use
of ezrin mutants, namely ezrin T567D and ezrin T567A. In
the T567D mutant, the threonine at position 567 is replaced
by a negatively charged aspartate, whichmimics a permanent
phosphorylation. The T567A mutant has been used in cell
experiments, where it is considered constitutively inactive
because the phosphorylation site is removed (17,18). We
compared the F-actin affinities of ezrin wild-type (wt) and
the two mutants bound via an N-terminal His-tag to
DOGS-NTA-Ni-bearing phospholipids with those of ezrin
derivatives bound to PIP2-containing SSMs.EXPERIMENTAL PROCEDURES
All materials used can be found in the SupportingMaterial. All buffers were
supplemented with 0.1 mM NaN3.Protein purification
Ezrin wild-type (wt) and the mutants T567A and T567D were recombi-
nantly expressed in Escherichia coli cells (strain BL21(DE3)pLysS) and
purified as described in detail elsewhere (19). Briefly, transformed E. coli
cells containing the bacterial expression vector pET28aþ (Novagen, Mad-
ison, WI) encoding ezrin wt, ezrin T567D, or ezrin T567A with an
N-terminal histidine tag were grown to an OD600 of 0.6. Protein expression
was induced by addition of isopropyl-b-D-thiogalactopyranoside (Sigma-
Aldrich, St. Louis, MO) to a concentration of 1 mM. After 4 h, cells
were harvested by centrifugation (3000  g, 10 min, 4C) and resuspended
in lysis buffer (40 mM HEPES, 20 mM imidazole, 300 mM NaCl, 1 mM
EDTA, 10 mM mercaptoethanol, and protease inhibitor mixtures
(Complete; Roche Diagnostics, Basel, Switzerland) at pH ¼ 7.4). Cell lysis
was induced by sonication. Subsequently, the lysates were centrifuged
(100,000  g, 1 h, 4C) and the supernatant was applied to a Ni-nitrilotri-
acetic acid (Ni-NTA) agarose column (Qiagen, Hilden, Germany) preequi-
librated with lysis buffer. The column was washed twice with lysis buffer
containing 25 mM imidazole/HCl at pH ¼ 7.4 and 35 mM imidazole/
HCl at pH ¼ 7.4, respectively. Ezrin was eluted using 300 mM imid-
azole/HCl at pH ¼ 7.4 and stored at 4C until use. Protein concentration
was determined by UV/Vis-spectroscopy using an extinction coefficient
of 3280 ¼ 66,900 M1 cm1.Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded on a model No. 810 spec-
trometer equipped with a model No. PTC432S temperature control unit
(both by JASCO, Gross-Umstadt, Germany) using the Spectra Manager
control (V 1.17.00) and application (V 1.53.00) software package (JASCO).
CD spectra were recorded in 20 mMKH2PO4/K2HPO4, and 0.1 mM EDTA,
pH ¼ 8 in 1-mm quartz glass precision cells at 20C in a wavelength range
of 240–190 nm with 1.0 nm bandwidth, using the continuous-mode setting,
with 1.0 s response and a scan speed of 50 nm/min. Five spectra were
averaged. Spectra were background-corrected against pure buffer,
smoothed (Savitzky-Golay), and expressed as mean residue ellipticity(103 deg,cm2,dmol1). For normalization, the final protein concentra-
tions were determined by UV/Vis-spectroscopy using pure buffer for back-
ground correction. Deconvolution of the data was performed using the
program DichroWeb (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml)
with algorithm CDSSTR and reference set 7 (20).Protein labeling
Ezrin wt was dissolved in 20 mM Tris/HCl, 50 mM KCl, 0.1 mM EDTA,
pH ¼ 7.4, at a concentration of 20 mM and mixed with dithiothreitol
(DTT) in a 10-fold molar excess to reduce possible disulfide bonds. The
solution was then dialyzed overnight against DTT-free, degassed buffer.
AlexaFluor633-maleimide dissolved in dimethyl sulfoxide was added drop-
wise to the protein solution at a molar ratio of 20:1 (AlexaFluor633-malei-
mide:ezrin) and the mixture was stirred overnight. The reaction mixturewas
quenched by the addition of 2 mMmercaptoethanol, and the labeled protein
was separated from free dye via size exclusion chromatography (Sephadex-
NAP 25; GE Life Sciences, Piscataway, NJ). All steps were carried out at
4C. The labeling efficiency was determined by UV/Vis-spectroscopy
(3632 ¼ 91,300 M1 cm1), resulting in a dye/protein ratio of 0.7:1.Actin polymerization
Nonmuscle G-actin was stored at a concentration of 10 mg/mL in G-buffer
(5 mM Tris/HCl, 0.2 mM CaCl2, 0.2 mM ATP, 5% (w/v) sucrose, and
1% (w/v) dextran, pH ¼ 8.0) at 80C. Before use, G-actin was dissolved
to a concentration of 0.4 mg/mL in G-buffer supplemented with 0.2 mM
DTT, kept on ice for 1 h to dissolve actin oligomers, and then cleared by
centrifugation (17,000  g, 10 min, 4C). Polymerization was induced
by adding 1/10 of the total volume of polymerization solution (500 mM
KCl, 20 mM MgCl2, and 20 mM ATP) to the actin solution. Phalloidin
was added in an equimolar amount compared to monomeric actin to prevent
depolymerization. For fluorescence microscopy, 0.01 mol % of Alexa-
Fluor488-phalloidin was added to label the actin filaments.Vesicle preparation
Mixed lipid films composed of POPC (2 mg/mL in chloroform) doped with
10 mol % of PIP2 (1 mg/mL in chloroform/methanol/water (20:5:1)) or
DOPC (2 mg/mL in chloroform) doped with 10 mol % of DOGS-NTA-
Ni (2 mg/mL in chloroform) were prepared at the bottom of glass test tubes
by removing the solvent under a stream of nitrogen. This was followed by
3 h under vacuum at 35C and storage at 4C. A quantity of 1 mol % of the
fluorophore perylene was added to the lipid mixture to allow us to observe
the integrity of the formed planar SSMs by fluorescence microscopy. If
defects are present in the membrane, they appear as dark spots in the fluo-
rescence images. Multilamellar vesicles were obtained by swelling the
lipid film in buffer solution (20 mM Tris/HCl, 50 mM KCl, 0.1 mM
EDTA, pH ¼ 7.4) for 30 min followed by rigorous vortexing of the suspen-
sion three times (30 s every 5 min). Multilamellar vesicles were trans-
formed into large unilamellar vesicles (LUVs) by the extrusion method
using a polycarbonate membrane with 100-nm pore diameter (LiposoFast;
Avestin, Ottawa, Canada).Preparation of solid-supported membranes
on gold substrates
For quartz crystal microbalance (QCM)-experiments, hybrid bilayers were
prepared on gold substrates. Immediately before use, the gold electrode of
the quartz plate (0.255 cm2) was cleaned in argon plasma for 5 min (Plasma
cleaner; Harrick Plasma, Ithaca, NY) and placed into the Teflon measuring
cell. The surface was immersed in an ethanolic octanethiol solution
(15 mM) for 1 h, rinsed first with ethanol and then with buffer (20 mMBiophysical Journal 100(7) 1708–1717
1710 Bosk et al.Tris/HCl, 50 mM KCl, and 0.1 mM EDTA, pH ¼ 7.4). The capacitance
of the resulting monolayer was monitored by impedance spectroscopy
(Solartron Instruments, Farnborough, UK) to verify complete coverage of
the gold electrode. A capacitance of (2.0 5 0.2) mF/cm2 indicated the
successful formation of an octanethiol monolayer. A second monolayer
was generated by incubating the hydrophobic surface with a suspension
of LUVs (0.5 mg/mL) for 2 h at room temperature. The quality of the result-
ing solid-supported bilayer was again analyzed by impedance spectroscopy.
Successful formation of bilayers was confirmed by capacitance values of
(1.2 5 0.2) mF/cm2. Remaining vesicles were removed by rinsing the
surface thoroughly with buffer solution.Preparation of solid-supported lipid bilayers
on silicon substrates
A silicon substrate (0.8  2.0 cm2) was rinsed thoroughly with isopropanol
and water. Then it was immersed in an aqueous solution of NH3 and H2O2
(5:1:1 H2O/NH3/H2O2) for 20 min at 70
C to render the surface hydro-
philic. The substrate was mounted into a flow cell chamber and immediately
incubated with the LUV suspension for 1–2 h. Subsequent rinsing with
buffer (20 mM Tris/HCl, 50 mM KCl, and 0.1 mM EDTA, pH ¼ 7.4)
removed remaining vesicles from the surface.Quartz crystal microbalance
For the investigation of protein-lipid interactions, the quartz crystal micro-
balance (QCM 200; Stanford Research Systems, Sunnyvale, CA) was used
in passive mode as described elsewhere (21). An AT-cut quartz plate with
a 5 MHz fundamental resonance frequency was mounted in a fluid cell
made of Teflon with the SSM facing the aqueous solution. Different protein
concentrations were added from outside the fluid cell in buffer with a buffer
flow of 0.35 mL/min to the SSM and the frequency shift was read-out in
a time-dependent manner.Fluorescence microscopy
An upright confocal laser scanning microscope (Zeiss LSM 710; Zeiss,
Jena, Germany) equipped with a water immersion objective with
63 magnification (W Plan Apochromat, NA ¼ 1.0, Zeiss) was used for
fluorescence imaging. Perylene fluorescence of the SSMs was excited at
405 nm (diode laser) and detected at 426–485 nm. Proteins were bound
to the membranes immobilized on silicon substrates by continuously flow-
ing buffer (0.35 mL/min) across the sample for 30 min. The protein-bound
fluorophore (AlexaFluor633) was excited with a 633-nm laser line and the
fluorescence detected at 640–660 nm. For the excitation of phalloidin
bound to filamentous actin (AlexaFluor488), an Ar-laser was used
(488 nm). Emission was collected in the range of 515–552 nm.TABLE 1 Results of the deconvolution of CD spectra
Ezrin T567A Ezrin wt Ezrin T567D
a-Helix/% 60 71 65
b-Sheet/% 7 4 4
Turns/% 8 7 9
Random coil/% 25 18 22
NRMSD* 0.019 0.007 0.016
CD spectra of ezrin T567A, ezrin wt, and ezrin T567D using the online
server DichroWeb (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml)
employing the algorithm CDSSTR and reference data set 7.
*Normalized root mean-squared deviation.RESULTS
Recently, we presented what we believe to be first results on
an in vitro system for the analysis of ezrin-mediated
membrane-F-actin interactions (16). Our findings suggested
that binding of ezrin wt to PIP2 embedded in a lipid bilayer
partially activates the protein, which then becomes capable
of binding F-actin. Based on this first evidence, we ad-
dressed the question whether phosphorylation of ezrin and
the binding to PIP2 act synergistically toward this activation.
To answer this question, we used two different ezrin mutants
in comparison to the wild-type (wt) protein, which are
frequently used in cell experiments (7,17). Ezrin T567A isBiophysical Journal 100(7) 1708–1717a mutant, in which threonine is replaced by alanine, which
prevents the phosphorylation of the protein in vivo. The
wild-type protein is also nonphosphorylated, as all experi-
ments were performed under nonphosphorylating condi-
tions and it is highly unlikely that a phosphorylation
occurs during recombinant expression in E. coli. In ezrin
T567D, threonine is exchanged against the negatively
charged amino acid aspartate, which mimics the negative
charge of the phosphorylated state. Each protein was equip-
ped with a His-tag at its N-terminus for purification
purposes and for binding the protein to a lipid membrane
containing the receptor lipid DOGS-NTA-Ni.
Before the binding experiments, the secondary structures
of the three different proteins were analyzed by CD spectro-
scopy to prove their structural integrity and to investigate
whether the mutations lead to structural changes of the
protein (see the Supporting Material). Deconvolution of the
CD spectra results in the secondary structure fractions as
summarized in Table 1. For all three proteins, a rather large
a-helical content in the range of 60–71% was found, while
b-sheet contributions to the overall structures were rather
small and in the range of only 4–7%. Interestingly, the
a-helical content for ezrin T567A is ~10% smaller than
that of the wt protein, even though one would not expect
a significant alteration of the protein’s structure by this single
point mutation. The change in secondary structure compared
to the wt protein is less pronounced for ezrin T567D. In this
case, a conformational change of the protein is discussed as
a result of the addition of the negative charge (22).Binding of ezrin wt and the mutants
to solid-supported membranes
Prerequisite for studying the capability of membrane-bound
ezrin to interact with F-actin is its binding to a lipid
membrane. In this study, we used planar bilayers attached
to a solid substrate as they allow us not only to quantify
ezrin binding to the membrane by surface-sensitive methods
such as the quartz crystal microbalance (QCM) technique but
also to visualize the interaction with F-actin. The QCM tech-
nique is a well-established quantitative method and allows
the investigation of protein binding to a functionalized
surface in a time-resolved and label-free fashion (21,23).
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of either DOPC/DOGS-NTA-Ni (9:1) or POPC/PIP2 (9:1)
was quantified. A content of 10 mol % of the receptor lipid
(DOGS-NTA-Ni or PIP2) in the membrane was chosen to
ensure maximum protein coverage (see the Supporting
Material) (24). Solid-supported hybrid membranes were
prepared on 5 MHz quartz plates composed of a chemi-
sorbed octanethiol monolayer and a second phospholipid
monolayer obtained from spreading large unilamellar vesi-
cles doped with the corresponding receptor lipid. Fig. 1, A
and B, shows representative time courses of the frequency
shifts of the quartz plate after several additions of ezrin wt
to a DOGS-NTA-Ni-containing membrane (Fig. 1 A) and
a PIP2-containing membrane (Fig. 1 B), respectively.
Upon addition of the protein, a time-dependent decrease
in resonance frequency of the quartz crystal is observed.
The decrease in resonance frequency is proportional to the
amount of ezrin adsorbed on the lipid layer. The value Df
is defined as the difference between the actual resonanceA
B
FIGURE 1 Representative time course of the frequency shift upon step-
wise ezrin wt addition (a–f) to a solid-supported (A) OT-DOPC/DOGS-
NTA-Ni (9:1) or (B) OT-POPC/PIP2 (9:1) membrane in 20 mM Tris/HCl,
50 mM KCl, 0.1 mM EDTA, pH ¼ 7.4. (g) Rinsing with pure buffer.
Concentrations in panel A: (a) 13 nM, (b) 39 nM, (c) 90 nM, (d)
161 nM, (e) 249 nM, and (f) 280 nM. Concentrations in panel B: (a)
19 nM, (b) 44 nM, (c) 91 nM, (d) 148 nM, (e) 233 nM, and (f) 282 nM.frequency f(t) and f(t ¼ 0). After several protein additions
under constant flow conditions, the surface coverage reaches
its maximum and no further decrease in resonance
frequency is observed. From the time-dependent changes
in resonance frequency, it can be deduced that equilibrium
is reached within 15–20 min.
To obtain the protein concentration required for full
membrane coverage the normalized frequency changes
Df/Dfmax at equilibrium obtained for each protein addition
were plotted versus the ezrin concentrations in solution
(Fig. 2). From the obtained adsorption isotherms, the protein
concentration required for full surface coverage was read
out. For all proteins, they were in the >100 nM regime. To
ensure that the membrane surface is saturated for all binding
scenarios, a protein concentration of c > 400 nM was used
for all experiments except for those where the membranes
were doped with only 0.5 mol % PIP2. The maximum
frequency shifts varied up to 30% and were independent of
the protein, in the range of 60 Hz. To analyze the reversibility
of protein binding, the measuring chamber was rinsed with
pure buffer. For all three proteins, 90% of the protein remains
bound to the DOGS-NTA-Ni-containing membrane, while
only ~10% of the protein could be removed by rinsing within
the observation time. For ezrin boundvia PIP2, a slightly larger
fraction desorbs from the surface upon rinsing (Table 2).
To model the isotherms and extract dissociation constants
KD of the protein-receptor interaction, we used:
K1D c ¼
Q
FðQÞ: (1)A B
C D
FIGURE 2 Adsorption isotherms of (A) ezrin T567A and (B) ezrin
T567D binding to a DOGS-NTA-Ni-doped (10 mol %) SSM. Adsorption
isotherms of (C) ezrin T567A and (D) ezrin T567D binding to a PIP2-doped
(10 mol %) SSM. All experiments were performed in 20 mM Tris/HCl,
50 mMKCl, and 0.1 mM EDTA, pH¼ 7.4. (Dashed lines) Results of fitting
Eq. 1 to the data. The results are summarized in Table 2. (Solid lines)
Results of fitting Eq. 3 to the data. For further details, see text.
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TABLE 2 Parameters obtained from QCM-measurements on three different ezrin species bound to DOGS-NTA-Ni or
PIP2-containing membranes
Membrane protein
DOGS-NTA-Ni PIP2
T567A wt T567D T567A wt T567D
Dfmax/Hz 585 13
(n ¼ 5)
675 19
(n ¼ 3)
645 5
(n ¼ 5)
66 5 4
(n ¼ 6)
465 8
(n ¼ 3)
49 5 5
(n ¼ 6)
Reversibility/% 95 7
(n ¼ 6)
75 5
(n ¼ 7)
85 2
(n ¼ 6)
16 5 10
(n ¼ 5)
195 11
(n ¼ 4)
14 5 7
(n ¼ 10)
KD/nM 475 6
(n ¼ 5)
145 2
(n ¼ 3)
215 5
(n ¼ 5)
45 5 12
(n ¼ 6)
525 32
(n ¼ 3)
18 5 9
(n ¼ 6)
Values are given as mean values 5 SD. The term n gives the number of independent experiments.
1712 Bosk et al.The value Q is the surface coverage and c is the protein
concentration. The model takes into account that the protein
area covering one binding site can expand over more than
one lattice space, which is given by the available surface
functionF(Q) (Eq. 2), which describes the available surface
for deposition of particles from bulk solution as a function
of coverage (scaled particle theory, SPT) (25):
FðQÞ ¼ ð1QÞexp

 3 Q
1Q

Q
1Q
2
: (2)
The model assumes that particle adsorption occurs nonco-
operatively on a homogeneous surface in a monomolecular
fashion, where all individual binding sites have the same
adsorption energy for the adsorbate. The resulting dissocia-
tion constants are summarized in Table 2.Visualization of membrane bound ezrin wt
and its interaction with F-actin
To visualize the binding behavior of ezrin to PIP2-contain-
ing membranes by fluorescence microscopy and to elucidate
the F-actin binding capability of membrane-bound ezrin, we
labeled ezrin wt with an AlexaFluor633 fluorescence dye.
SSMs composed of POPC doped with only 0.5 mol %
PIP2 were prepared by spreading of large unilamellar vesi-
cles on hydrophilic silicon substrates. Such low PIP2
concentration was chosen to ensure that only part of the
membrane surface is covered with ezrin (see the Supporting
Material), which can thus be readily distinguished from
noncovered regions (24). This allows us not only to investi-
gate the organization of the protein on the membrane
surface but also to visualize how F-actin binds to partly
ezrin-decorated membranes.
After 30 min of incubation with 200 nM of Alexa-
Fluor633-labeled protein, the membrane surface was rinsed
with buffer to remove nonbound protein, and fluorescence
images were taken. The images show that ezrin forms
protein clusters several tens of micrometers in size and of
irregular shape. A characteristic protein cluster found on
the membrane surface is depicted in Fig. 3 A (see also the
Supporting Material). This result indicates that the protein
not only binds to PIP2 in the membrane but is capable ofBiophysical Journal 100(7) 1708–1717laterally aggregating on the surface, which might be an
indication of a positive cooperative binding behavior as
discussed below.
To elucidate whether ezrin wt bound via PIP2 specifically
interacts with F-actin, we added an F-actin solution supple-
mented with phalloidin to stabilize the filaments and Alexa-
Fluor488 phalloidin for fluorescence labeling. After 30 min
of incubation and rinsing with buffer, the membrane surface
was again inspected by fluorescence microscopy. Filamen-
tous structures of actin became visible in the fluorescence
images (Fig. 3 B). High concentrations of surface-bound
F-actin were only found in those areas where ezrin wt was
localized (Fig. 3 C). Only a small number of actin filaments
were detected in areas where no ezrin was bound, which
can be attributed to nonspecific adsorption of F-actin to
the membrane surface. These results demonstrate that
PIP2-bound ezrin wt is capable of specifically binding
F-actin, suggesting that an exposure of the F-actin binding
site in the C-ERMAD has taken place.F-actin binding of ezrin mutants and ezrin wt
The QCM results have confirmed that ezrin wt as well as
ezrin T567D and T567A adsorb specifically on DOPC/
DOGS-NTA-Ni (9:1) and POPC/PIP2 (9:1) membranes,
respectively, and that the main fraction remains bound
even after rinsing with buffer. From the QCM results we
also determined the required protein concentration in solu-
tion to obtain maximum surface coverage on membranes
containing 10 mol % of the receptor lipid. These concentra-
tions were, independent of the protein, in the >100-nM
regime.
We also showed that F-actin is capable of binding with
high specificity to ezrin wt, when it is bound to PIP2-con-
taining membranes. To be able to elucidate and quantify
the influence of the phosphorylation state of ezrin and its
binding to PIP2 on the F-actin binding capability as well
as a possible synergism, a combination of the different
protein derivatives and the membrane-binding mode is
required. Solid-supported lipid bilayers composed of
DOPC/DOGS-NTA-Ni (9:1) and POPC/PIP2 (9:1), respec-
tively, were prepared on hydrophilic silicon substrates
by fusion of large unilamellar vesicles. Each membrane
AC
B
FIGURE 3 Confocal laser scanning fluorescence microscopy image
of (A) AlexaFluor633-maleimide-labeled ezrin wt immobilized on a SSM
containing 0.5% PIP2, 1% perylene, 98.5% POPC in F-buffer (20 mM
Tris/HCl, 50 mM KCl, 2 mM MgCl2, and 2 mM ATP, pH ¼ 7.4). (B)
AlexaFluor488-phalloidin-labeled actin. (C) Overlay of the two images.
Scale bars: 5 mm.
Synergistic Effects on Ezrin Activation 1713preparation was inspected by confocal laser scanning fluo-
rescence microscopy using the membrane-confined fluoro-
phore perylene.
A homogeneous fluorescence indicated a successful
membrane formation (data not shown). Protein concentra-
tions larger than 400 nM were used to obtain maximum
protein coverage on the membrane. Each protein was incu-
bated with the membrane under flow conditions for 30 minand the surface was rinsed afterwards with F-buffer. An
F-actin solution stabilized with phalloidin and labeled
with AlexaFluor 488 phalloidin was then added for
30 min to the membrane-bound ezrin derivatives. After
rinsing the samples with pure buffer to remove nonbound
F-actin, they were analyzed by confocal laser scanning fluo-
rescence microscopy. These images allowed us to visualize
directly the amount and structure of bound F-actin on the
membrane.
Representative fluorescence images of the six possible
different samples are depicted in Fig. 4 showing the green
fluorescence of the phalloidin-labeled actin filaments that
have an average length of ~1–7 mm as determined from
the fluorescence images by pixel analysis. While ezrin
T567A bound via its His-tag recruits only few surface-
bound individual actin filaments, we found an almost
complete surface coverage of F-actin on surfaces, where
ezrin T567D was immobilized via PIP2. To obtain quantita-
tive data from the fluorescence images and be able to
compare the results, we performed a detailed pixel analysis
using the program ImageJ (National Institutes of Health,
Bethesda, MD). The process of determining a threshold
value in every individual picture is described in the Support-
ing Material.
Based on this approach, mean F-actin surface coverage
values for DOGS-NTA-Ni-containing membranes of (155
9)% (n ¼ 8) for membrane-bound ezrin T567A, (21 5
10)% (n¼ 13) for ezrinwt, and (585 23)% (n¼ 10) for ezrin
T567D were obtained (Fig. 5). The surface coverage ob-
tained for ezrin T567A bound to DOGS-NTA-Ni is almost
the same as that obtained for membranes incubated with
F-actinwithout bound protein ((145 6)%, n¼ 4). This result
implies that F-actin binding to membrane-bound ezrin
T567A cannot be safely attributed to a specific interaction.
Only a slightly larger surface coveragewas observed for ezrin
wt bound via its His-tag to the membrane. It is expected that
binding of ezrin wt and ezrin T567A via their N-terminal
His-tags to a DOGS-NTA-Ni-containing membrane
preserves their dormant conformation, i.e., that they do
not expose the F-actin binding site, which in turn results in
a rather low or even no affinity to F-actin. Ezrin T567D,
however, mimics the phosphorylated (activated) state and
it is thus supposed that this mutant is capable of binding
F-actin, even if bound via its His-tag to DOGS-NTA-Ni-
doped membranes. Indeed, a significant increase in surface
coverage to almost 60% is observed.
In the second set of experiments, the influence of PIP2
binding in conjunction with the three different proteins
was elucidated. The most striking results were obtained
for ezrin wt and the pseudophosphorylated mutant T567D.
If ezrin wt is bound via PIP2 to the SSM, the F-actin surface
coverage increased by more than a factor of two to (49 5
27)% (n ¼ 14) compared to the value obtained for ezrin
wt bound via its His-tag. This result suggests a partial acti-
vation of ezrin wt through PIP2 binding, as reportedBiophysical Journal 100(7) 1708–1717
DOGS-NTA-Ni + T567A     DOGS-NTA-Ni + wt                         
PIP  + T567A              2
DOGS-NTA-Ni + T567D
PIP  + T567D2PIP  + wt              2
FIGURE 4 Confocal laser scanning fluorescence microscopy images of AlexaFluor488-phalloidin-labeled actin bound to ezrin on DOGS-NTA-Ni (10%)
doped SSMs or PIP2 (10%) doped SSMs on silicon substrates using ezrin T567A, ezrin wt, and ezrin T567D as indicated. Scale bars: 10 mm.
1714 Bosk et al.previously (16). The influence of PIP2 on the activation state
could also be observed for the pseudophosphorylated
mutant ezrin T567D. In this case, the F-actin surface
coverage increased to (935 11)% (n ¼ 13) (Fig. 5), which0
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FIGURE 5 Quantification of the surface coverage via pixel analysis
using the program ImageJ (National Institutes of Health). Results obtained
for DOGS-NTA-Ni (10 mol %) (open bars) and PIP2 (10 mol %) (hatched
bars) doped SSMs on silicon substrates using ezrin and the mutants. These
data were generated from at least 2–3 independently prepared samples,
from which 3–7 images were taken at different regions of the surface for
coverage determination. The values are given as mean values 5 SD.
AWilcoxon rank-sum test confirms that the difference in F-actin coverage
is significantly different for ezrin wt bound to DOGS-NTA-Ni and PIP2
(P ¼ 0.0007, *) and ezrin T567D bound to DOGS-NTA-Ni and PIP2
(P ¼ 0.007, *). In addition, the differences in F-actin coverage comparing
ezrin wt and ezrin T567D bound to DOGS-NTA-Ni (P ¼ 0.00003, **) and
ezrin wt and ezrin T567D bound to PIP2 (P ¼ 0.0004, **) showed high
significance.
Biophysical Journal 100(7) 1708–1717is significantly larger than that obtained for ezrin T567D
bound via its His-tag. This strongly implies that the syner-
gistic action of PIP2 binding and the negative charge in posi-
tion 567 results in the exposure of the F-actin binding site,
which corresponds to full activation of ezrin.
Interestingly, an F-actin surface coverage of only (15 5
13)% (n ¼ 20) was found for ezrin T567A bound to PIP2-
containing membranes, which is very similar to the value
obtained for ezrin T567A bound to DOGS-NTA-Ni-doped
membranes. Without bound protein, a nonspecific F-actin
binding of (85 3)% (n¼ 5) surface coverage was observed
in the case of PIP2-containing membranes, which is lower
than the adsorption of F-actin on DOGS-NTA-Ni-containing
membranes ((145 6)%). This difference can be attributed to
the different net surface charges. While at pH 7.4, the PIP2-
doped membrane is negatively charged (a charge of 3
to 5 per PIP2 (26)), the DOGS-NTA-Ni-doped membrane
is only slightly negatively charged (a charge of 1 per
DOGS-NTA-Ni (27)). Because actin filaments are also
negatively charged (28), a larger electrostatic repulsion is
expected on PIP2-containing membranes consistent with
the observed lower F-actin adsorption on those membranes.
Because the surface is considerably altered after adsorption
of ezrin to either membrane type, we refrained from subtract-
ing the nonspecific adsorption values from the specific ones.DISCUSSION
The activation of ezrin that results in F-actin binding is
thought to occur through conformational changes, which
Synergistic Effects on Ezrin Activation 1715can be triggered by events such as the binding of PIP2 or the
Ca2þ-regulated protein S100P (19) to the N-terminal ERM
association domain (N-ERMAD) and the phosphorylation
of the conserved Thr-567 in the actin binding C-ERMAD.
While earlier studies of the mechanism of this activation re-
vealed that phosphorylation is the key step (29,30), more
recently a two-step model of activation has been favored,
in which ERM proteins are recruited to membrane regions
that are enriched in PIP2, thus rendering the conserved threo-
nine residue more accessible to phosphorylation (12,13).
To elucidate the specific interaction and adhesion of F-actin
with membrane-bound ezrin in a quantitative manner, we
performed in vitro studies on ezrin wt and two mutants
mimicking the phosphorylated (T567D) state of the protein
and one that cannot be phosphorylated in vivo (T567A).
By means of the QCM technique in conjunction with
receptor-doped SSMs, we first demonstrated that all three
proteins bind with high specificity to either DOGS-NTA-
Ni via the N-terminal His-tag or to PIP2. PIP2 is known as
a specific interaction partner of ezrin. Binding is based on
the interaction between two lysine-rich, basic regions in
the N-terminal region of the protein and the phosphate
groups of PIP2. This structure resembles a PH-domain,
which is the typical binding motif in PIP2-binding proteins.
The QCM technique has been proven to be a versatile tool to
monitor protein-lipid interactions in a label-free and time-
resolved manner (21,31). Here, it allowed us to determine
the protein concentrations required for maximum surface
coverage, which were, independent of the protein, in the
100-nM range.
Previously, we demonstrated by atomic force microscopy
and by analyzing the kinetics of ezrin binding that the
protein laterally aggregates on PIP2-doped membranes
(24). This result is corroborated by fluorescence images ob-
tained for AlexaFluor-labeled ezrin bound to PIP2-contain-
ing membranes in this study (Fig. 3), showing that large
protein aggregates are formed on PIP2-doped membranes.
Several studies suggest that ezrin forms oligomers when
bound to the membrane (6,32), while the protein in solution
is mainly monomeric with some dimers (33). Such an inter-
action of adsorbed protein molecules on the surface has not
been considered in the SPT-model used to evaluate the
adsorption isotherms (Eq. 1). However, the Bragg-Williams
approximation offers a simple solution to treat the adsor-
bate/adsorbate interaction in an average sense leading to
an analytical expression for the adsorption isotherm (34):
Q
FðQÞ ¼ K
1
D c exp

3 Q
kT

: (3)
The value 3 is the average protein-protein interaction energy
on the surface in units of kT. The results of fitting the Bragg-
Williams model to the experimental isotherms are plotted
together with the results obtained from the SPT model in
Fig. 2, C and D. With the Bragg-Williams isotherm, a disso-ciation constant for ezrin T567A of KD ¼ 104 nM is found
with an average interaction energy of 3 ¼ 5 kT. The nega-
tive value indicates that the neighboring particles have
a stabilizing effect. The dissociation constant KD describing
only the protein-receptor interaction is increased compared
to that without the assumption of positive cooperativity, as
expected. A very similar result was obtained for the adsorp-
tion isotherm of ezrin wt to PIP2 with KD ¼ 121 nM and
3 ¼ 6 kT. These values are in agreement with that used
in a previous study (24). Of note, even though a stabilizing
effect (i.e., positive cooperativity) is assumed, the modeled
isotherms do not deviate significantly from those of the
SPT-model (see Fig. 2 C). A slightly more pronounced
deviation is only observed for the mutant ezrin T567D,
where a KD ¼ 235 nM and 3 ¼ 10 kT was obtained.
The results demonstrate that positive cooperativity of
protein binding cannot be ruled out just from the fact that
a model such as the scaled particle isotherm is in accordance
with the measured isotherms. Additional experimental
evidence is required such as fluorescence microscopy
images, which demonstrated the formation of large protein
clusters. The formation of lateral protein aggregates is
also reflected in the finding that the majority of the protein
remains bound on the surface within the observed time
period, while only a minor fraction desorbs upon rinsing,
which can be attributed to a reduced overall desorption—
an effect arising from the lateral attraction of the proteins
on the membrane surface.
By means of fluorescence microscopy, we were not only
able to show the colocalization of F-actin and protein clus-
ters but we could also quantify the amount of bound actin
filaments, which turned out to be a function of the phosphor-
ylation state of the protein and its binding mode. We suggest
that an increased F-actin binding capacity of the protein is
a direct measure of its activation state, i.e., the exposure
of the F-actin binding site in the C-ERMAD. A very
large surface coverage of >90% was observed for the
pseudophosphorylated mutant T567D bound to PIP2, in
full agreement with the two-step model, which suggests
a fully activated state of the protein under conditions of
phosphorylation and binding to the natural receptor lipid
PIP2 at the same time.
A comparison of this F-actin surface coverage with the
value (~60%) obtained if the pseudophosphorylated mutant
is bound via DOGS-NTA-Ni clearly demonstrates that even
though the protein is still capable of binding actin filaments
to a large extent, a significant increase in activation occurs
as a result of its binding to PIP2. There is also some evidence
from in vivo experiments that PIP2 contributes to the activa-
tion of ezrin. For example, Auvinen et al. (14) reported that
an upregulation of PIP-kinase leads to a colocalization of
activated ERM proteins and F-actin. A similar observation
has been reported by Matsui et al. (35). They examined
PI4P5K-overexpressing cells, in which ERM proteins
were recruited to plasma membranes to form microvilli.Biophysical Journal 100(7) 1708–1717
1716 Bosk et al.A comparison of the F-actin binding capacity of ezrin wt
with that of ezrin T567D bound via PIP2 identifies a syner-
gism of PIP2 binding and phosphorylation of ezrin. It is
obvious that ezrin wt has a decreased F-actin binding
capacity, i.e., it is less activated than the ezrin T567D
mutant. However, it still binds considerably more F-actin
(~50% surface coverage) than if it is bound via DOGS-
NTA-Ni (~20% surface coverage). This is consistent with
our previous results, where we were able to show that
PIP2 not only serves as a membrane anchor, but is capable
of partly activating ezrin in such a way that a conformational
change unmasks the F-actin binding site in the C-ERMAD
(16). Taking these results together, it can be concluded
that the interaction of ezrin wt and ezrin T567D with PIP2
induces a conformational switch that renders the F-actin
binding site accessible. The F-actin binding affinity is then
further enhanced by the negative charge in position 567
mimicking the phosphorylated state in vivo.
The situation is different for ezrin T567A. Independent
of the mode of binding to the membrane, an F-actin surface
coverage of only roughly 15% is found, which is in the
same range as F-actin adsorption/protein-free membranes
(14% for DOGS-NTA-Ni- and 8% for PIP2-containing
membranes). This result suggests that the mutant ezrin
T567A is not partially activated by the binding to PIP2,
as was observed for ezrin wt. This further supports the
view that the amino acid at position 567 plays a crucial
role in the conformational switch, which exposes the F-actin
binding site. A reason for this behavior might be that
alanine in position 567 locks the protein in its dormant
conformation, which is not as easily transformed to the
active state as in the native protein ezrin wt.
The results we obtained for the secondary structure
elements of ezrin T567A and ezrin wt using CD spectro-
scopy further support our view that the structure, and as
a consequence, the binding ability of the inactive mutant,
might be affected by the mutation. That is, deviation in
the a-helical as well as random coil contents from those
obtained for ezrin wt suggest that a structural change is
introduced by the replacement of threonine for alanine in
this mutant.CONCLUSIONS
In conclusion, our results are in good agreement with the
model proposed recently for moesin activation (12). The
authors found that, depending on the cellular context, PIP2
binding is essential for the first activation step, and at the
same time often sufficient for the establishment of
membrane-cortex connections. The second activation step,
i.e., phosphorylation of Thr-567, is required for the forma-
tion and maintenance of specialized cellular structures.
Based on their results, they introduced the idea that phos-
phorylation acts as fine-tuning on PIP2-bound ERM
proteins.Biophysical Journal 100(7) 1708–1717An earlier study of Yonemura et al. (10) also reaches the
conclusion that, at least in some cell types, activation of
ERM proteins does not necessarily require phosphorylation,
but is regulated by a local increase in the PIP2 concentration.
Indeed, our in vitro results strongly support this model,
proving that ezrin wt can be activated through PIP2 binding,
which is demonstrated in an enhanced F-actin binding
capability, and that C-terminal phosphorylation mimicked
by ezrin T567D provides additional stability for the acti-
vated state.SUPPORTING MATERIAL
Materials, CD spectra, additional QCM data, CLSM fluorescence images of
ezrin wt clustering, and description of data evaluation are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(11)00259-1.
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